Growth Metrics

Rxo (RXO) Short-Term Debt repayments (2023 - 2025)

Rxo (RXO) has disclosed Short-Term Debt repayments for 3 consecutive years, with $95.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short-Term Debt repayments rose 187.88% year-over-year to $95.0 million, compared with a TTM value of $533.0 million through Dec 2025, up 135.84%, and an annual FY2025 reading of $533.0 million, up 135.84% over the prior year.
  • Short-Term Debt repayments was $95.0 million for Q4 2025 at Rxo, down from $211.0 million in the prior quarter.
  • Across five years, Short-Term Debt repayments topped out at $265.0 million in Q1 2025 and bottomed at -$38.0 million in Q2 2025.
  • Average Short-Term Debt repayments over 3 years is $92.2 million, with a median of $71.0 million recorded in 2023.
  • Peak annual rise in Short-Term Debt repayments hit 754.84% in 2025, while the deepest fall reached 162.3% in 2025.
  • Year by year, Short-Term Debt repayments stood at $71.0 million in 2023, then plummeted by 53.52% to $33.0 million in 2024, then skyrocketed by 187.88% to $95.0 million in 2025.
  • Business Quant data shows Short-Term Debt repayments for RXO at $95.0 million in Q4 2025, $211.0 million in Q3 2025, and -$38.0 million in Q2 2025.